Equities
Health CareHealth Care Providers
  • Price (USD)332.24
  • Today's Change-0.76 / -0.23%
  • Shares traded1.55k
  • 1 Year change+33.67%
  • Beta1.6629
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HCA Healthcare, Inc. is a health care services company. The Company owns, manages or operates hospitals, freestanding surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. It also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices and other facilities. It operates about 186 hospitals, comprised of 178 general, acute care hospitals, six behavioral hospitals and two rehabilitation hospitals.

  • Revenue in USD (TTM)69.62bn
  • Net income in USD5.93bn
  • Incorporated2010
  • Employees220.00k
  • Location
    HCA Healthcare IncOne Park PlazaNASHVILLE 37203United StatesUSA
  • Phone+1 (615) 344-9551
  • Fax+1 (302) 655-5049
  • Websitehttps://hcahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HCA:NYQ since
announced
Transaction
value
Valesco Holdings LLCDeal completed28 Aug 202428 Aug 2024Deal completed-14.85%--
Data delayed at least 15 minutes, as of Nov 22 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Molina Healthcare Inc39.20bn1.14bn16.94bn18.00k15.033.5412.780.43219.7019.70674.9783.682.56--13.712,177,722.007.477.6216.5816.8016.1215.992.923.04--14.830.34650.006.5612.5237.759.0622.87--
Quest Diagnostics Inc9.54bn838.00m18.29bn40.00k22.002.7013.701.927.457.4584.7960.790.64534.777.18238,475.005.879.286.7710.8132.9436.649.1012.971.178.870.474625.07-6.384.20-9.773.401.277.43
Labcorp Holdings Inc12.71bn435.50m20.09bn67.00k46.542.4619.021.585.165.16150.4097.610.716219.415.93189,743.302.466.273.007.3727.9232.333.449.511.305.590.455--2.511.42-62.16-16.403.62--
Natera Inc1.53bn-214.69m20.95bn3.28k--23.93--13.67-1.77-1.7712.597.081.0114.295.45466,774.80-14.14-36.17-17.55-46.6057.6645.88-14.01-56.154.23--0.2947--31.9933.2620.63--58.81--
Centene Corp161.73bn3.07bn30.47bn67.70k10.471.137.090.18845.775.77303.7253.531.94--9.572,388,863.003.662.586.393.9910.3711.591.891.37--4.060.39110.006.5420.70124.7924.593.43--
Humana Inc115.01bn1.36bn35.61bn67.60k26.182.0314.810.309611.2911.29948.23145.882.17----1,701,331.002.727.57--------1.253.35--5.380.424912.5414.5413.33-11.307.6510.4113.25
CVS Health Corp368.91bn5.02bn71.86bn300.00k14.510.95857.490.19483.943.94290.6059.571.4617.7836.331,229,707.001.993.032.974.2014.2017.071.362.300.58723.880.46640.4610.9512.9593.55--8.273.89
HCA Healthcare Inc69.62bn5.93bn84.16bn220.00k14.91--8.351.2122.2822.28261.95-8.571.225.547.29316,459.1011.9811.9916.8815.7584.8584.109.8110.170.99915.300.98210.547.866.84-7.1110.135.8311.38
Cigna Group232.59bn3.04bn91.81bn72.50k31.132.1914.710.394710.6010.60811.50150.611.5143.489.913,208,083.002.184.093.305.5511.2113.981.443.610.77362.330.436813.698.1732.15-22.9714.4224.40161.81
Elevance Health Inc174.02bn6.42bn93.60bn104.90k14.712.1411.990.537927.4427.44743.42188.741.53----1,658,866.005.636.03--------3.673.96--8.360.382220.189.4213.211.589.971.4214.56
Data as of Nov 22 2024. Currency figures normalised to HCA Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

26.03%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202415.17m5.88%
Sanders Capital LLCas of 30 Sep 202411.54m4.47%
BlackRock Fund Advisorsas of 30 Sep 20248.89m3.45%
SSgA Funds Management, Inc.as of 30 Sep 20248.32m3.22%
Wellington Management Co. LLPas of 30 Sep 20246.53m2.53%
First Eagle Investment Management LLCas of 30 Sep 20244.48m1.74%
Geode Capital Management LLCas of 30 Sep 20243.82m1.48%
Capital Research & Management Co. (World Investors)as of 30 Sep 20242.91m1.13%
Norges Bank Investment Managementas of 30 Jun 20242.87m1.11%
RBC Global Asset Management (UK) Ltd.as of 30 Sep 20242.64m1.02%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.